Q2 2019

Filed Aug 1, 2019 · 10-Q · 32 days after period end · 0001104506-19-000020

Q2 2019 · 10-Q

Revenue

$29.97M

— vs Q2 2018

Net Income

-$66.51M

N/M vs Q2 2018

EPS Diluted

-$0.81

N/M vs Q2 2018

Gross Profit$25,053,000—

Operating Income

Same quarter

Metric	Q2 2019	Q2 2018	Q2 2017	Q2 2016
Revenue	$29.97M	$0.00	$0.00	$0.00
Net Income	-$66.51M	-$76.44M	-$44.67M	-$36.58M
EPS Diluted	-$0.81	-$1.00	-$0.72	-$0.59

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR